Ginkgo Bioworks Stock - Not Looking Good
Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Signup now at https://www.nanalyze.com/nanalyze-weekly/. This episode is pulled from a YouTube presentation. View the original presentation at https://youtu.be/qQOVwnmJQm8.
#Synbio darling Ginkgo Bioworks $DNA released their 2022 results along with a 10-K filing. We perused all their year-end collateral for insights, starting with a strong increase in Foundry revenues from third parties and falling related party revenues. That's the good news. The bad news is that downstream value isn't looking so hot…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.